Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial

Toru Arai; Hiroshi Kida; Yoshitaka Ogata; Satoshi Marumo; Hiroto Matsuoka; Iwao Gohma; Suguru Yamamoto; Masahide Mori; Chikatoshi Sugimoto; Kazunobu Tachibana; Masanori Akira; Yoshikazu Inoue

doi:10.1136/bmjresp-2020-000558

Article info

XML

Interstitial lung disease

Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial

Authors

Toru Arai Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan PubMed articles Google scholar articles
Hiroshi Kida Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita City, Osaka, JapanDepartment of Respiratory Medicine, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka City, Osaka, Japan PubMed articles Google scholar articles
Yoshitaka Ogata Department of Emergency and Critical Care Medicine, Hiroshima University, Hiroshima City, Hiroshima, Japan PubMed articles Google scholar articles
Satoshi Marumo Respiratory Disease Center, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka City, Osaka, Japan PubMed articles Google scholar articles
Hiroto Matsuoka Department of Respiratory Medicine, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, Habikino City, Osaka, Japan PubMed articles Google scholar articles
Iwao Gohma Department of Respiratory Medicine, Sakai City Medical Center, Sakai City, Osaka, Japan PubMed articles Google scholar articles
Suguru Yamamoto Department of Respiratory Medicine, National Hospital Organization Osaka Minami Medical Center, Kawachinagano City, Osaka, Japan PubMed articles Google scholar articles
Masahide Mori Department of Respiratory Medicine, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka City, Osaka, Japan PubMed articles Google scholar articles
Chikatoshi Sugimoto Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan PubMed articles Google scholar articles
Kazunobu Tachibana Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan PubMed articles Google scholar articles
Masanori Akira Department of Radiology, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan PubMed articles Google scholar articles
Yoshikazu Inoue Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan PubMed articles Google scholar articles

Correspondence to Dr Yoshikazu Inoue; giichiyi{at}me.com

View Full Text

Citation

Arai T, Kida H, Ogata Y, et al

Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial

BMJ Open Respiratory Research 2020;7:e000558. doi: 10.1136/bmjresp-2020-000558

Publication history

Received January 5, 2020
Revised February 24, 2020
Accepted April 16, 2020
First published May 17, 2020.

Online issue publication

November 15, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.